About IBD BioResource

The IBD BioResource is a national platform designed to expedite research into Crohn’s disease and ulcerative colitis and help develop new and better therapies.

The IBD BioResource is an integral part of the NIHR BioResource for Translational Research, which provides the major nationally accessible resource of over 200,000 volunteers from the general population and patients with common and rare diseases. The NIHR BioResource and IBD BioResource are working collaboratively in supporting studies looking at how genes and other factors may influence diseases.

Key goals

  • To recruit 50,000 patients with Crohn’s or colitis from all over the UK, including 1000 newly diagnosed
  • Genetic analysis will identify markers of disease risk, severity and treatment response
  • Participants will be directly notified of future IBD research projects they might be willing to help with and be recalled for
  • Scientists and Clinical Investigators will have rapid access to large groups of IBD patients for research

Funding statement

The IBD BioResource is funded and supported by these partners and also by industry partners.

Last Updated on